Diseases, Conditions, Syndromes

Epithelial thickness is marker for gastroesophageal reflux

(HealthDay)—Epithelial thickness seems to be a marker for gastroesophageal reflux disease (GERD), according to research published in the November issue of Clinical Gastroenterology and Hepatology.

Oncology & Cancer

Antacids linked to better survival in head and neck cancer

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study from the University of Michigan Comprehensive Cancer Center.

Alzheimer's disease & dementia

Taking proton pump inhibitors not linked to higher dementia risk

Proton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of 2011, up to 1 in 5 older adults reported using a PPI. Although ...

Diseases, Conditions, Syndromes

Suboptimal usage of proton pump inhibitors common

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), those who receive a proton pump inhibitor (PPI) prescription from gastroenterologists are more likely to be optimal users and have better symptom control, ...

Diseases, Conditions, Syndromes

AGA releases best practice advice on long-term PPI use

When proton pump inhibitors (PPIs) are appropriately prescribed, their benefits are likely to outweigh their risks, according to an American Gastroenterological Association (AGA) Clinical Practice Update1 published in Gastroenterology, ...

Diseases, Conditions, Syndromes

Heartburn controlled with step down to once daily therapy

(HealthDay) -- The majority of gastroesophageal reflux disease (GERD) patients who take twice-daily proton pump inhibitor (PPI) therapy, are able to successfully step down to management of heartburn with a daily dose of dexlansoprazole ...

page 10 from 19